20th Jan 2010 08:46
Wednesday 20 January 2010
Allergy Therapeutics plc
("Allergy Therapeutics" or "the Company")
Notification of Interim Results and Trading update
Allergy Therapeutics plc (AIM: AGY), the specialist pharmaceutical company focused on allergy vaccination, will announce its interim results for the six months ended 31 December 2009 on 1 March 2010. The Company expects to report net sales of £27.3m; in line with market expectations.
Historically, Allergy Therapeutics' sales are heavily skewed towards the first half of the Company's financial year.
For further information
|
Allergy Therapeutics |
+44 (0) 1903 845 821 |
|
Ian Postlethwaite Finance Director |
|
|
Manuel Llobet Chief Executive Officer |
|
|
www.allergytherapeutics.com |
|
|
Nomura Code Securities |
+44 (0) 207 776 1200 |
|
Juliet Thompson/ Clare Terlouw |
|
Related Shares:
Allergy Thera.